Company news

Amphastar Pharmaceuticals, Inc. news in 2021

Amphastar Pharmaceuticals, Inc.'s news releases, calls and decks from 2021, newest first.

View company

Amphastar Receives FDA Tentative Approval for Vasopressin

December 28, 2021

Amphastar Pharmaceuticals to Present at the Piper Sandler 33rd Annual Virtual Healthcare Conference

November 21, 2021

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2021

November 7, 2021

Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 8th, 2021

October 27, 2021

Amphastar Pharmaceuticals to Present at the Wells Fargo 2021 Virtual Healthcare Conference

September 1, 2021

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2021

August 8, 2021

Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 9th, 2021

July 28, 2021

Amphastar Pharmaceuticals to Present at the Raymond James Human Health Innovation Conference

June 14, 2021

Amphastar Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference

May 26, 2021

Amphastar Announces Buyback of 26% of the Equity in its ANP Subsidiary and Spin-off its Hanxin Subsidiary

May 6, 2021

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2021

May 5, 2021

Amphastar Pharmaceuticals Receives FDA Approval for Morphine Sulfate Injection

May 2, 2021

Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 6th, 2021

April 28, 2021

Amphastar Pharmaceuticals to Present at the 20th Annual Needham Virtual Healthcare Conference

April 5, 2021

Amphastar Pharmaceuticals Receives FDA Approval for Dextrose Injection

March 28, 2021

Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full-Year Ended December 31, 2020

March 14, 2021

Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on March 15th, 2021

March 7, 2021

Amphastar Pharmaceuticals to Present at the Raymond James 2021 Institutional Healthcare Conference

February 25, 2021

Decks in 2021